Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Apellis Pharmaceuticals Inc (APLS)
NASDAQ:APLS
RESEARCH TOOLSreports
Apellis Pharmaceuticals (APLS) Ownership - Who Owns Apellis Pharmaceuticals?
738 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Apr 15, 2024 | A. Sinclair Dunlop Director | Bought | $19785 |
| Mar 20, 2024 | A. Sinclair Dunlop Director | Sold | $1067993 |
| Mar 19, 2024 | Mark Jeffrey Delong Chief Business & Strat Officer | Sold | $564050 |
| Mar 18, 2024 | James George Chopas Vp/chief Accounting Officer | Sold | $10389 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $359 | |
| Dec 31, 2023 | Bought | $210288 | |
| Dec 31, 2023 | Sold | $359160 | |
| Dec 31, 2023 | Bought | $11147368 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,503,375 | Institution | 7.83% | 391,539,050 | |
| 9,103,469 | Institution | 7.50% | 375,062,923 | |
| 8,642,821 | Institution | 7.12% | 356,084,225 | |
| 2,362,866 | Institution | 1.95% | 97,350,079 | |
| 2,068,000 | Institution | 1.70% | 85,201,600 | |
| 1,919,679 | Institution | 1.58% | 79,090,775 | |
| 1,819,215 | Institution | 1.50% | 74,951,658 | |
| 1,434,948 | Institution | 1.18% | 59,119,858 | |
| 1,346,600 | Institution | 1.11% | 55,479,920 | |
| 1,333,249 | Institution | 1.10% | 54,929,859 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,503,375 | Institution | 7.83% | 391,539,050 | |
| 8,642,821 | Institution | 7.12% | 356,084,225 | |
| 1,919,679 | Institution | 1.58% | 79,090,775 | |
| 1,819,215 | Institution | 1.50% | 74,951,658 | |
| 1,346,600 | Institution | 1.11% | 55,479,920 | |
| 1,333,249 | Institution | 1.10% | 54,929,859 | |
| 1,322,109 | Institution | 1.09% | 54,470,891 | |
| 1,320,687 | Institution | 1.09% | 54,412,304 | |
| 1,154,079 | Institution | 0.95% | 47,548,055 | |
| 1,086,076 | Institution | 0.89% | 44,746,331 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,163,668 | Institution | 2.61% | 185,960,405 | |
| 2,569,174 | Institution | 2.12% | 151,016,048 | |
| 1,526,684 | Institution | 1.26% | 89,738,486 | |
| 1,454,532 | Institution | 1.20% | 85,497,391 | |
| 1,164,291 | Institution | 0.96% | 50,076,156 | |
| 701,500 | Institution | 0.58% | 28,901,800 | |
| 483,657 | Institution | 0.40% | 20,802,088 | |
| 438,582 | Institution | 0.36% | 18,069,578 | |
| 242,127 | Institution | 0.20% | 14,232,225 | |
| 342,023 | Institution | 0.28% | 14,091,348 |
FAQ
Who Owns Apellis Pharmaceuticals Inc (APLS)?
Currently, no data Available
What percentage of Apellis Pharmaceuticals Inc (APLS) stock is held by institutional investors?
Currently, no data Available
What percentage of Apellis Pharmaceuticals Inc (APLS) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Apellis Pharmaceuticals Inc (APLS)?
VANGUARD SPECIALIZED FUNDS owns the most shares of Apellis Pharmaceuticals Inc (APLS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.